Man Group PLC Pacira Bio Sciences, Inc. Transaction History

Man Group PLC

$37.6 Billion
Q2 2024

A detailed history of Man Group PLC transactions in Pacira Bio Sciences, Inc. stock. As of the latest transaction made, Man Group PLC holds 90,606 shares of PCRX stock, worth $1.49 Million. This represents 0.01% of its overall portfolio holdings.

Number of Shares

90,606

Previous 52,785 71.65%

Holding current value

$1.49 Million

Previous $1.54 Million 68.09%

% of portfolio

0.01%

Previous 0.0%

22 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 14, 2024	BUY	$25.5 - $31.51 $964,435 - $1.19 Million	37,821 Added 71.65%	90,606 $2.59 Million
Q1 2024 May 15, 2024	SELL	$27.7 - $35.48 $722,914 - $925,957	-26,098 Reduced 33.08%	52,785 $1.54 Million
Q4 2023 Feb 14, 2024	BUY	$26.32 - $34.31 $40,006 - $52,151	1,520 Added 1.96%	78,883 $2.66 Million
Q3 2023 Nov 14, 2023	BUY	$30.68 - $40.09 $564,481 - $737,615	18,399 Added 31.2%	77,363 $2.37 Million
Q2 2023 Aug 14, 2023	BUY	$36.12 - $47.5 $817,287 - $1.07 Million	22,627 Added 62.27%	58,964 $2.36 Million
Q1 2023 May 15, 2023	SELL	$35.53 - $43.38 $2.14 Million - $2.62 Million	-60,370 Reduced 62.43%	36,337 $1.48 Million
Q4 2022 Feb 14, 2023	BUY	$38.19 - $57.45 $3.69 Million - $5.56 Million	96,707 New	96,707 $3.73 Million
Q2 2022 Aug 15, 2022	BUY	$51.49 - $81.64 $737,903 - $1.17 Million	14,331 New	14,331 $836,000
Q1 2022 May 16, 2022	SELL	$60.03 - $76.49 $314,797 - $401,113	-5,244 Closed	0 $0
Q4 2021 Feb 14, 2022	BUY	$47.97 - $62.21 $251,554 - $326,229	5,244 New	5,244 $316,000
Q1 2021 May 17, 2021	SELL	$59.31 - $78.82 $4.49 Million - $5.96 Million	-75,647 Closed	0 $0
Q4 2020 Feb 16, 2021	SELL	$50.47 - $66.26 $6.21 Million - $8.15 Million	-122,990 Reduced 61.92%	75,647 $4.53 Million
Q3 2020 Nov 16, 2020	SELL	$51.97 - $63.0 $605,034 - $733,446	-11,642 Reduced 5.54%	198,637 $11.9 Million
Q2 2020 Aug 14, 2020	SELL	$30.8 - $52.47 $911,803 - $1.55 Million	-29,604 Reduced 12.34%	210,279 $11 Million
Q1 2020 May 15, 2020	BUY	$28.4 - $50.7 $4.45 Million - $7.94 Million	156,663 Added 188.25%	239,883 $8.04 Million
Q4 2019 Feb 18, 2020	BUY	$36.31 - $46.83 $1.95 Million - $2.52 Million	53,774 Added 182.62%	83,220 $3.77 Million
Q3 2019 Nov 14, 2019	BUY	$35.66 - $44.99 $408,164 - $514,955	11,446 Added 63.59%	29,446 $1.12 Million
Q2 2019 Aug 14, 2019	BUY	$36.57 - $47.97 $658,260 - $863,460	18,000 New	18,000 $783,000
Q1 2019 May 15, 2019	SELL	$36.47 - $42.17 $518,493 - $599,530	-14,217 Closed	0 $0
Q4 2018 Feb 14, 2019	SELL	$41.31 - $52.16 $1.31 Million - $1.65 Million	-31,600 Reduced 68.97%	14,217 $612,000
Q3 2018 Nov 14, 2018	BUY	$32.85 - $52.0 $1.08 Million - $1.72 Million	33,018 Added 257.97%	45,817 $2.25 Million
Q2 2018 Aug 14, 2018	BUY	$27.5 - $39.8 $351,972 - $509,400	12,799 New	12,799 $410,000

Others Institutions Holding PCRX

# of Institutions

266

Shares Held

49.4M

Call Options Held

378K

Put Options Held

1.43M

View Full List

About Pacira BioSciences, Inc.

Ticker PCRX
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 45,824,200
Market Cap $754M
Description
Pacira BioSciences, Inc. provides non-opioid pain management and regenerative health solutions for healthcare practitioners and their patients in the United States. The company offers EXPAREL, a bupivacaine liposome injectable suspension; ZILRETTA, a triamcinolone acetonide extended-release injectable suspension; and iovera system, a non-opioid ...

More about PCRX

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Man Group PLC, based on Form 13F filings with the SEC.

News

Stay updated on Man Group PLC with notifications on news.

Account